# Remimazolam for Emergence Delirium Prevention in Children Undergoing Tonsillectomy

> **NCT07704437** · PHASE1 · COMPLETED · sponsor: **University Hospital of Split** · enrollment: 110 (actual)

## Conditions studied

- Remimazolam
- Tonsillectomy
- Emergence Delirium

## Interventions

- **DRUG:** Remimazolam 20 MG Injection [Byfavo]
- **DRUG:** NaCl (0,9%)

## Key facts

- **NCT ID:** NCT07704437
- **Lead sponsor:** University Hospital of Split
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-01
- **Primary completion:** 2025-07-15
- **Final completion:** 2026-05-05
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2026-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07704437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07704437, "Remimazolam for Emergence Delirium Prevention in Children Undergoing Tonsillectomy". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07704437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*